
Sign up to save your podcasts
Or
With several vaccines on the way, 2021 promises to be a great year for equities. Earnings could reach double-digit growth and the trend of underperformance in value stocks could grind to a hold, say Jeroen Blokland and Peter van der Welle in our latest podcast episode. It’s also a time for non-US stocks to outperform their US equivalents. Tune in to hear it all.
5
22 ratings
With several vaccines on the way, 2021 promises to be a great year for equities. Earnings could reach double-digit growth and the trend of underperformance in value stocks could grind to a hold, say Jeroen Blokland and Peter van der Welle in our latest podcast episode. It’s also a time for non-US stocks to outperform their US equivalents. Tune in to hear it all.
191 Listeners
95 Listeners
588 Listeners
979 Listeners
1,855 Listeners
925 Listeners
798 Listeners
178 Listeners
63 Listeners
1,280 Listeners
75 Listeners
66 Listeners
212 Listeners
0 Listeners
73 Listeners